Pulmonary Edema in COVID-19 Treated with Furosemide and Negative Fluid Balance (NEGBAL): A Different and Promising Approach
Authors:
- Jose L. Francisco SantosJSJose L. Francisco Santos
- Patricio ZanardiPZPatricio Zanardi
- Veronica AloVAVeronica Alo
- Marcelo RodriguezMRMarcelo Rodriguez
- Federico MagdalenoFMFederico Magdaleno
- Virginia De LangheVLVirginia De Langhe
- Vanina Dos SantosVSVanina Dos Santos
- Giuliana MurialdoGMGiuliana Murialdo
- Andrea VilloldoAVAndrea Villoldo
- Micaela CoriaMCMicaela Coria
- Diego QuirosDQDiego Quiros
- Claudio MilicchioCMClaudio Milicchio
Open Access
- 28 November 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5599
Abstract
In COVID-19, pulmonary edema has been attributed to “cytokine storm”. However, it is known that SARS-CoV2 promotes angiotensin-converting enzyme 2 deficit, increases angiotensin II, and this triggers volume overload. Our report is based on COVID-19 patients with tomographic evidence of pulmonary edema and volume overload to whom established a standard treatment with diuretic (furosemide) guided by objectives: Negative Fluid Balance (NEGBAL approach). Retrospective observational study. We reviewed data from medical records: demographic, clinical, laboratory, blood gas, and chest tomography (CT) before and while undergoing NEGBAL, from 20 critically ill patients. Once the NEGBAL strategy was started, no patient required mechanical ventilation. All cases reverted to respiratory failure with NEGBAL, but subsequently two patients died from sepsis and acute myocardial infarction (AMI). The regressive analysis between PaO2/FiO2BAL and NEGBAL demonstrated correlation (p < 0.032). The results comparing the Pao2Fio2 between admission to NEGBAL to NEGBAL day 4, were statistically significant (p < 0.001). We noted between admission to NEGBAL and day 4 improvement in CT score (p < 0.001), decrease in the superior vena cava diameter (p < 0.001) and the decrease of cardiac axis (p < 0.001). Though our study has several limitations, we believe the promising results encourage further investigation of this different pathophysiological approach.Keywords
This publication has 54 references indexed in Scilit:
- Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyxCritical Care, 2014
- Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cellsAmerican Journal of Physiology-Renal Physiology, 2008
- Recent advances in the angiotensin‐converting enzyme 2–angiotensin(1–7)–Mas axisExperimental Physiology, 2008
- Acute Pulmonary EdemaNew England Journal of Medicine, 2005
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Angiotensin-converting enzyme 2 protects from severe acute lung failureNature, 2005
- The new biology of aldosteroneJournal of Endocrinology, 2005
- The Pathogenesis of Acute Pulmonary Edema Associated with HypertensionNew England Journal of Medicine, 2001
- Clinical and Radiologic Features of Pulmonary EdemaRadioGraphics, 1999
- RAISED VENOUS PRESSURE: A DIRECT CAUSE OF RENAL SODIUM RETENTION IN OEDEMA?The Lancet, 1988